These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 21182632)
1. Usefulness of platelet (PLT) pathogen inactivation technology: a case of Sphingomonas paucimobilis inactivation in an apheresis PLT unit. Jimenez-Marco T; Girona-Llobera E; Ruiz-Veramendi M; Sedeño M; Muncunill J Transfusion; 2010 Nov; 50(11):2503-4. PubMed ID: 21182632 [No Abstract] [Full Text] [Related]
2. Sphingomonas paucimobilis: a persistent Gram-negative nosocomial infectious organism. Ryan MP; Adley CC J Hosp Infect; 2010 Jul; 75(3):153-7. PubMed ID: 20434794 [TBL] [Abstract][Full Text] [Related]
3. Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004. Fang CT; Chambers LA; Kennedy J; Strupp A; Fucci MC; Janas JA; Tang Y; Hapip CA; Lawrence TB; Dodd RY; Transfusion; 2005 Dec; 45(12):1845-52. PubMed ID: 16371037 [TBL] [Abstract][Full Text] [Related]
4. Sphingomonas paucimobilis bacteremia in humans: 16 case reports and a literature review. Lin JN; Lai CH; Chen YH; Lin HL; Huang CK; Chen WF; Wang JL; Chung HC; Liang SH; Lin HH J Microbiol Immunol Infect; 2010 Feb; 43(1):35-42. PubMed ID: 20434121 [TBL] [Abstract][Full Text] [Related]
5. Recurrent Sphingomonas paucimobilis -bacteraemia associated with a multi-bacterial water-borne epidemic among neutropenic patients. Perola O; Nousiainen T; Suomalainen S; Aukee S; Kärkkäinen UM; Kauppinen J; Ojanen T; Katila ML J Hosp Infect; 2002 Mar; 50(3):196-201. PubMed ID: 11886195 [TBL] [Abstract][Full Text] [Related]
6. Sphingomonas paucimobilis osteomyelitis in an immunocompetent patient. A rare case report and literature review. Pascale R; Russo E; Esposito I; Leone S; Esposito S New Microbiol; 2013 Oct; 36(4):423-6. PubMed ID: 24177306 [TBL] [Abstract][Full Text] [Related]
7. Water-borne Sphingomonas paucimobilis epidemic in an intensive care unit. Meric M; Willke A; Kolayli F; Yavuz S; Vahaboglu H J Infect; 2009 Mar; 58(3):253-5. PubMed ID: 19232740 [No Abstract] [Full Text] [Related]
13. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Eder AF; Kennedy JM; Dy BA; Notari EP; Weiss JW; Fang CT; Wagner S; Dodd RY; Benjamin RJ; Transfusion; 2007 Jul; 47(7):1134-42. PubMed ID: 17581147 [TBL] [Abstract][Full Text] [Related]
14. Factors affecting platelet yield and their impact on the platelet increment of patients receiving single donor PLT transfusion. Enein AA; Hussein EA; El Shafie S; Hallouda M J Clin Apher; 2007 Feb; 22(1):5-9. PubMed ID: 17266120 [TBL] [Abstract][Full Text] [Related]
15. Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors. Picker SM; Radojska SM; Gathof BS Transfusion; 2006 Sep; 46(9):1601-8. PubMed ID: 16965590 [TBL] [Abstract][Full Text] [Related]
16. Septic arthritis caused by Sphingomonas paucimobilis in an immunocompetent patient. Souto A; Guinda M; Mera A; Pardo F Reumatol Clin; 2012; 8(6):378-9. PubMed ID: 22902983 [No Abstract] [Full Text] [Related]
17. Preparation of highly concentrated and white cell-poor platelet-rich plasma by plateletpheresis. Zimmermann R; Reske S; Metzler P; Schlegel A; Ringwald J; Eckstein R Vox Sang; 2008 Jul; 95(1):20-5. PubMed ID: 18444946 [TBL] [Abstract][Full Text] [Related]